Cite

HARVARD Citation

    Cooke, S. et al. (n.d.). OC-0609: The PET-boost trial: isotoxic homogeneous or FDG-directed dose escalation in stage II-III NSCLC. Radiotherapy and oncology. pp. S345-S346. [Online]. 
  
Back to record